Microbiological diagnosis and mortality of tuberculosis meningitis: Systematic review and meta-analysis
- PMID: 36795648
- PMCID: PMC9934382
- DOI: 10.1371/journal.pone.0279203
Microbiological diagnosis and mortality of tuberculosis meningitis: Systematic review and meta-analysis
Abstract
Background: Tuberculosis (TB) which is caused by Mycobacterium tuberculosis poses a significant public health global treat. Tuberculosis meningitis (TBM) accounts for approximately 1% of all active TB cases. The diagnosis of Tuberculosis meningitis is notably difficult due to its rapid onset, nonspecific symptoms, and the difficulty of detecting Mycobacterium tuberculosis in cerebrospinal fluid (CSF). In 2019, 78,200 adults died of TB meningitis. This study aimed to assess the microbiological diagnosis TB meningitis using CSF and estimated the risk of death from TBM.
Methods: Relevant electronic databases and gray literature sources were searched for studies that reported presumed TBM patients. The quality of included studies was assessed using the Joanna Briggs Institute Critical Appraisal tools designed for prevalence studies. Data were summarized using Microsoft excel ver 16. The proportion of culture confirmed TBM, prevalence of drug resistance and risk of death were calculated using the random-effect model. Stata version 16.0 was used perform the statistical analysis. Moreover, subgroup analysis was conducted.
Results: After systematic searching and quality assessment, 31 studies were included in the final analysis. Ninety percent of the included studies were retrospective studies in design. The overall pooled estimates of CSF culture positive TBM was 29.72% (95% CI; 21.42-38.02). The pooled prevalence of MDR-TB among culture positive TBM cases was 5.19% (95% CI; 3.12-7.25). While, the proportion of INH mono-resistance was 9.37% (95% CI; 7.03-11.71). The pooled estimate of case fatality rate among confirmed TBM cases was 20.42% (95%CI; 14.81-26.03). Based on sub group analysis, the pooled case fatality rate among HIV positive and HIV negative TBM individuals was 53.39% (95%CI; 40.55-66.24) and 21.65% (95%CI;4.27-39.03) respectively.
Conclusion: Definite diagnosis of TBM still remains global treat. Microbiological confirmation of TBM is not always achievable. Early microbiological confirmation of TBM has great importance to reduce mortality. There was high rate of MDR-TB among confirmed TBM patients. All TB meningitis isolates should be cultured and drug susceptibility tested using standard techniques.
Copyright: © 2023 Seid et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures






Similar articles
-
Evaluation of the GeneXpert MTB/RIF in patients with presumptive tuberculous meningitis.PLoS One. 2018 Jun 18;13(6):e0198695. doi: 10.1371/journal.pone.0198695. eCollection 2018. PLoS One. 2018. PMID: 29912907 Free PMC article.
-
Multidrug-resistant tuberculous meningitis in children in Durban, South Africa.Pediatr Infect Dis J. 2006 Feb;25(2):147-50. doi: 10.1097/01.inf.0000199314.88063.4c. Pediatr Infect Dis J. 2006. PMID: 16462292
-
Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children.Cochrane Database Syst Rev. 2020 Aug 27;8(8):CD013359. doi: 10.1002/14651858.CD013359.pub2. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2022 Sep 6;9:CD013359. doi: 10.1002/14651858.CD013359.pub3. PMID: 32853411 Free PMC article. Updated.
-
Epidemiological, clinical characteristics and drug resistance situation of culture-confirmed children TBM in southwest of China: a 6-year retrospective study.BMC Infect Dis. 2020 May 1;20(1):318. doi: 10.1186/s12879-020-05041-3. BMC Infect Dis. 2020. PMID: 32357835 Free PMC article.
-
A Systematic Review and Meta-analysis of the Diagnostic Accuracy of Nucleic Acid Amplification Tests for Tuberculous Meningitis.J Clin Microbiol. 2019 May 24;57(6):e01113-18. doi: 10.1128/JCM.01113-18. Print 2019 Jun. J Clin Microbiol. 2019. PMID: 30944198 Free PMC article.
Cited by
-
Nanopore-targeted sequencing (NTS) for intracranial tuberculosis: a promising and reliable approach.Ann Clin Microbiol Antimicrob. 2024 Oct 9;23(1):89. doi: 10.1186/s12941-024-00751-x. Ann Clin Microbiol Antimicrob. 2024. PMID: 39385187 Free PMC article.
-
Development and validation of a diagnostic model for tuberculous meningitis based on laboratory data.Front Cell Infect Microbiol. 2025 May 20;15:1579827. doi: 10.3389/fcimb.2025.1579827. eCollection 2025. Front Cell Infect Microbiol. 2025. PMID: 40463505 Free PMC article.
-
Current Insights into Diagnosing and Treating Neurotuberculosis in Adults.CNS Drugs. 2023 Nov;37(11):957-972. doi: 10.1007/s40263-023-01047-y. Epub 2023 Nov 17. CNS Drugs. 2023. PMID: 37978095 Review.
-
Mortality predictors and diagnostic challenges in adult tuberculous meningitis: a retrospective cohort of 100 patients.Trop Med Health. 2025 Apr 24;53(1):58. doi: 10.1186/s41182-025-00738-0. Trop Med Health. 2025. PMID: 40275342 Free PMC article.
-
Sequential testing with Xpert MTB/RIF assay for diagnosis of tuberculous meningitis in Maharaj Nakorn Chiang Mai University Hospital.Sci Rep. 2025 Jan 29;15(1):3675. doi: 10.1038/s41598-025-87739-5. Sci Rep. 2025. PMID: 39881189 Free PMC article.
References
-
- Global tuberculosis report 2021. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources